http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2006016600-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-46 |
| filingDate | 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2006016600-A1 |
| titleOfInvention | Tartaric acid derivative and cross-linked polymer synthesized by the derivative |
| abstract | Cross-linking agents and condensing agents that have been used in the past for treating biomedical adhesives and medical devices such as heart valves are artificially synthesized non-natural products, and are toxic without being metabolized in vivo. , An organic solvent is required for dissolution. Therefore, development of a water-soluble crosslinking agent having high biocompatibility has been desired. One or more of succinimidyl, sulfosuccinimidyl, maleimidyl, phthalimidyl, imidazolylyl, nitrophenyl, and toresyl which are electron-withdrawing groups for carboxyl groups of tartaric acid and its derivatives having a hydroxyl group in the molecule, or two or more of these derivatives. A water-soluble tartaric acid derivative modified by a combination of the above and a crosslinked polymer obtained by the tartaric acid derivative. |
| priorityDate | 2004-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.